Certor SRL
The score of Certor shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +78 % Total assets +73 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Certor's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | 56,702 € | ||||
| Equity | 486,561 € | ||||
| Cash | 21,366 € | ||||
| EBITDA | 100,981 € | ||||
| Total assets | 505,224 € |
Filed annual accounts
- Year ended 31 Mar 2026filed on 26 Oct 2026
- Year ended 31 Mar 2025filed on 24 Oct 2025
- Year ended 31 Mar 2024filed on 29 Oct 2024
- Year ended 31 Mar 2023filed on 30 Oct 2023
- Year ended 31 Mar 2022filed on 31 Oct 2022
Certor's financial analysis
- Solvency96.3%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Certor
Certor's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0845.063.505
- VAT number
- BE0845063505
- Peppol
- Registered · 0208:0845063505 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Mar 2012
- Registered office
- 2800 Mechelen
- Latest accounts
- 2026 · filed on 26 Oct 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Certor (SRL) has been based in Mechelen since 2012, active in: research and experimental development on biotechnology. For 2026, it reports a net profit of 56,702 € and equity of 486,561 €; its revenue is not published. Its solvency stands at 96.3%, above the median of its sector (60.4%).
Companies similar to Certor
Companies in the same business, of comparable size and area, outside its group.
- Semaphar Research and experimental development on natural sciences and engineering Jodoigne · balance sheet 579,404 €
- Huisarts Nadine Costers Research and experimental development on natural sciences and engineering Knokke-Heist · balance sheet 502,719 €
- Opero Research and experimental development on natural sciences and engineering Grimbergen · balance sheet 225,981 €
- Thalen Biotech Consultancy Research and experimental development on natural sciences and engineering Frasnes-lez-Anvaing · balance sheet 215,550 €
- Belma Technologies Research and experimental development on natural sciences and engineering Liège · balance sheet 281,040 €
- Bio-Perspectives Research and experimental development on natural sciences and engineering Ixelles · balance sheet 206,760 €
- Loxia Consulting Research and experimental development on natural sciences and engineering Watermael-Boitsfort · balance sheet 325,836 €
- Blue Armor Research and experimental development on natural sciences and engineering Neupré · balance sheet 489,312 €
Frequently asked questions about Certor
What is the revenue of Certor?
Certor files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Certor?
In Belgium, the VAT number is the company number prefixed with BE: BE0845063505 for Certor, if the company is VAT-registered. Its company number (CBE) is 0845.063.505.
Where is the registered office of Certor?
According to the CBE register, the registered office of Certor is in 2800 Mechelen.
What is the equity of Certor?
At the close of the 2026 financial year, the equity of Certor amounts to 486,561 €, a solvency of 96.3% of total assets.
Who manages Certor?
The register lists 2 active mandates at Certor. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Certor
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →